Related Experiment Videos
Recurrence of hydatid disease
T D Sielaff1, B Taylor, B Langer
1Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.
World Journal of Surgery
|February 24, 2001
Summary
Hepatic hydatid disease recurrence after surgery is about 10%, often due to parasite spillage. Early diagnosis via serology and imaging, followed by albendazole and targeted treatment, is key for managing recurrence.
Area of Science:
- Hepatology
- Parasitology
- Surgical Oncology
Background:
- Surgical treatment for hepatic hydatid disease carries a ~10% local recurrence rate.
- Recurrence typically results from intraoperative parasite spillage or incomplete cyst wall removal.
Purpose of the Study:
- To review the diagnosis and management of recurrent hepatic hydatid disease.
- To emphasize the importance of vigilant follow-up and appropriate therapeutic strategies.
Main Methods:
- Literature review focusing on recurrence factors, diagnostic modalities, and treatment outcomes.
- Analysis of diagnostic methods including serology, ultrasonography, and computed tomography.
- Evaluation of therapeutic options: albendazole, interventional radiotherapy, and surgical re-intervention.
Main Results:
- Incomplete resection or parasite spillage are primary causes of recurrence.
- Asymptomatic recurrence necessitates regular patient follow-up with serological and imaging studies.
- Albendazole administration is a crucial component in managing recurrent disease.
Conclusions:
- Effective management of recurrent hepatic hydatid disease requires early diagnosis and a tailored therapeutic approach.
- Preserving liver function and minimizing patient risk are paramount in treating recurrence.
- Multimodal treatment strategies, including antiparasitic medication and targeted interventions, improve outcomes.